Loading BioAtlas...
Loading BioAtlas...
Comparez modèles biologiques, moteurs de docking et flux de calcul côte à côte. Filtrez par modèle d'accès, empreinte de calcul et catégorie pour parvenir à une table de décision exploitable en moins d'une minute.
| Attribut | ＋ Ajouter un outil | |||||
|---|---|---|---|---|---|---|
| Category | Biological Foundation Models | Biological AI Models | Biological AI Models | Biological AI Models | Biological AI Models | — |
| Subcategory | Antibody Design | Protein Design | Protein Design | Protein Design | Protein Design | — |
| Company | University of Oxford (OPIG) | Pacesa Lab | Boltz Team | Baker Lab | Google DeepMind | — |
| Access mode | Open Source | Research code or publication | Research code or publication | Research code or publication | Research Preview | — |
| Licence conditions | BSD-3-Clause | Check code and model weights separately | Check code and model weights separately | Check code and model weights separately | Research Publication / DeepMind Research | — |
| Compute requirements | 1x GPU or multi-core CPU | Check selected checkpoint and runtime; no GPU catalog recommendation | Check selected checkpoint and runtime; no GPU catalog recommendation | Check selected checkpoint and runtime; no GPU catalog recommendation | GPU cluster for generative diffusion sampling and candidate filtering | — |
| Biological application | Antibody humanization, CDR affinity maturation, and de novo paratope design | Non enregistré | Non enregistré | Non enregistré | De novo binder design, targeted cancer therapeutics, viral inhibitors, and biosensors | — |
| Research workflow | Input antibody backbone structure -> output high-affinity, humanized sequence candidates | Non enregistré | Non enregistré | Non enregistré | Specify target protein structure and epitope binding site -> generate de novo binder sequences and 3D backbones | — |
| Evidence level | Peer-reviewed publication (Nature Communications 2024) | Peer-reviewed primary method | Primary research preprint | Primary research preprint | DeepMind Research Whitepaper & arXiv preprint (2024) | — |
| Commercial eligibility | Open source permissive | Unknown, requires audit | Unknown, requires audit | Unknown, requires audit | Research publication & early academic collaboration | — |
| Price | Free Open Source | Check selected model licence | Check selected model licence | Check selected model licence | Research Preview | — |
| Availability ⓘ | Available on GitHub and PyPI | Public research method/code | Public research method/code | Public research method/code | DeepMind research publication and ongoing academic collaboration | — |
| Features | Specialized inverse folding model for antibody heavy and light chains, Trained on non-redundant experimental structures from SAbDab and AlphaFold-Multimer predictions, Generates antibody sequence libraries with high stability and developability profiles, Fast inference suitable for screening millions of candidate CDR loops | AF2-guided optimization pipeline proposes protein binder designs for target structures., Candidate binder sequences, modeled protein complexes | Target-conditioned protein and peptide binder generation model as reported in its preprint., Binder sequence and structure candidates | All-atom protein structure diffusion conditioned on specific ligand or nucleic acid atomic context., Generated protein all-atom structures | Generates high-affinity protein binders for diverse target proteins without initial starting fragments, Trained on large macromolecular structure repositories and AlphaFold predictions, Demonstrates up to 300-fold higher binding affinities than prior computational design methods, Experimental success rates ranging from 9% to 88% across diverse target proteins in wet-lab biophysical assays | — |
| Entry type | AI Model | Research AI model / method | Research AI model / method | Research AI model / method | AI Model | — |
| AI role | Antibody Optimization | Published biomedical AI method | Published biomedical AI method | Published biomedical AI method | De Novo Binder Design | — |
| Input data | Non enregistré | Target protein 3D coordinates; AF2/MPNN workflow and target interface constraints | Target context; design constraints | Target atomic geometry; designed region and constraints | Non enregistré | — |
| Output data | Non enregistré | Candidate binder sequences; modeled protein complexes | Binder sequence and structure candidates | Generated protein all-atom structures | Non enregistré | — |
| Validation | Non enregistré | Requires independent dataset-specific evaluation | Requires independent dataset-specific evaluation | Requires independent dataset-specific evaluation | Non enregistré | — |
| Type | Antibody inverse folding model | Non enregistré | Non enregistré | Non enregistré | Generative protein binder design model | — |
| Intended use | Non enregistré | Non enregistré | Non enregistré | Non enregistré | Non enregistré | — |
| Compatibility | Non enregistré | Non enregistré | Non enregistré | Non enregistré | Non enregistré | — |
| Manufacturer | University of Oxford | Non enregistré | Non enregistré | Non enregistré | Google DeepMind | — |
| Integration evidence | https://github.com/oxpig/AntiFold | Non enregistré | Non enregistré | Non enregistré | https://deepmind.google/discover/blog/alphaproteo-generates-novel-proteins-for-biology-and-health-research/ | — |
| Laboratory handoff | Candidates compatible with high-throughput antibody expression and SPR binding assays | Non enregistré | Non enregistré | Non enregistré | Designed binder sequences are ordered as synthetic DNA for yeast surface display and SPR/BLI affinity validation | — |